APA (7th ed.) Citation

Agogo-Mawuli, P. S., Gross, J. D., Setola, V., Gall, B. J., & Siderovski, D. P. (2025). Functional Variation in RGS12 Should Not Preclude Methylphenidate Use in Bipolar Disorder with Established Mood Stabilization: Preclinical Evidence. International Journal of Molecular Sciences, 26(24), 11993. https://doi.org/10.3390/ijms262411993

Chicago Style (17th ed.) Citation

Agogo-Mawuli, Percy S., Joshua D. Gross, Vincent Setola, Bryan J. Gall, and David P. Siderovski. "Functional Variation in RGS12 Should Not Preclude Methylphenidate Use in Bipolar Disorder with Established Mood Stabilization: Preclinical Evidence." International Journal of Molecular Sciences 26, no. 24 (2025): 11993. https://doi.org/10.3390/ijms262411993.

MLA (9th ed.) Citation

Agogo-Mawuli, Percy S., et al. "Functional Variation in RGS12 Should Not Preclude Methylphenidate Use in Bipolar Disorder with Established Mood Stabilization: Preclinical Evidence." International Journal of Molecular Sciences, vol. 26, no. 24, 2025, p. 11993, https://doi.org/10.3390/ijms262411993.